No Data
No Data
No Data
No Data
No Data
Curative Biotechnology, Inc. Announces Nomination of Dr. Theresa Heah to Board of Directors
Appointment of Independent Director Nominee to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Jan. 08, 2024 (GLOBE NEWSWIRE) -- Curative Biotech
GlobeNewswireJan 8 09:45 ET
Curative Biotechnology, Inc. Announces Nomination of Dr. Jeffrey Liebmann to Board of Directors
Appointment of Independent Director to become effective upon approval by and listing of common stock on a National Exchange Boca Raton, FL, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology I
GlobeNewswireOct 31, 2023 09:45 ET
Curative Biotechnology Announces Establishment of Japanese Subsidiary for Licensing Transactions and Asset Acquisitions
Appoints Paul Michaels Co-CEO of Parent and CEO of Subsidiary Boca Raton, FL, June 06, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) ("Curative Biotech" or the "Company"), a devel
GlobeNewswireJun 6, 2023 09:50 ET
Curative Biotechnology, Inc. Files Patent on Ophthalmic Formulation
Topical Administration Capable of Delivering Metformin to Choroid, RPE, and Retina Boca Raton, FL, May 24, 2023 (GLOBE NEWSWIRE) -- Curative Biotechnology Inc. (OTC: CUBT) ("Curative Biotech" or the
GlobeNewswireMay 24, 2023 10:12 ET
Curative Biotechnology, Inc. (CUBT) Announces January 31st IPO
Curative Biotechnology, Inc. (CUBT) plans to raise $8 million in an initial public offering (IPO) on Tuesday, January 31st, IPO Scoop reports. The company will issue 1,300,000 shares at a price of $6
Defense WorldJan 23, 2023 01:01 ET
No Data
No Data